60
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Hughes–Stovin syndrome with pulmonary aneurysms and renal dysfunction mimicking polyarteritis nodosa

ORCID Icon, , , &
Pages 107-112 | Received 22 Jun 2017, Accepted 09 Sep 2017, Published online: 26 Sep 2017
 

Abstract

Hughes–Stovin syndrome (HSS) is an extremely rare condition characterised by pulmonary artery aneurysms and deep vein thrombosis (DVT). We report the case of a 34-year-old Senegalese man who initially presented with fever, hemoptysis, and cough. Radiological and laboratory evaluation revealed right pulmonary artery aneurysms, intense inflammatory reaction, and renal dysfunction with protein and occult blood in urine. Vasculitis-like polyarteritis nodosa was suspected, and the patient was treated with oral high-dose prednisolone (PSL) followed by intravenous cyclophosphamide (IVCY). In the course of treatment, he developed bilateral leg edema, and DVT was revealed; he was finally diagnosed with HSS. As the findings of thrombi in the inferior vena cava extend to the level of the renal vein, the cause of renal dysfunction was suspected to be renal vein thrombosis. Continuing treatment with oral PSL and IVCY successfully improved his condition, resulting in remission.

Conflict of interest

None.

Patient consent

The patient provided informed consent for publication of this case report and the accompanying images.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.